VLP Biotech

VLP Biotech is a private U.S. biotechnology company developing epitope-based vaccines and recombinant protein products using a proprietary virus-like particle platform built on woodchuck hepatitis virus core antigen. The company appears focused primarily on infectious disease vaccines, with disclosed programs in chronic hepatitis B/hepatitis D, malaria, and anthrax. Its platform is designed to display selected antigens or epitopes on highly immunogenic VLP particles and is also used for custom recombinant protein and vaccine design services. Publicly available information indicates the company remains active, privately held, and preclinical, with operations centered in San Diego, California.